B+
Bull case
20%
Probability
Target price
$17.00
Analysis reference price unavailable
Analysis 2026-08-18 · RankAlpha Sentiment Codex
WW
WW InternationalDNasdaq / Consumer Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$14.25
Analysis reference price unavailable
Analysis 2026-08-18 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$9.00
Analysis reference price unavailable
Analysis 2026-08-18 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-18
Recent news sentiment (30D)
+0.1
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+49.4
Score
AI commentary
Primary Q2 reporting was constructive on Clinical, Core+, ARPU, margins, and guidance, but the overall evidence remains mixed because legacy Behavioral pressure and execution risks persist. Recent headline flow is active, while social data, analyst revisions, options data, short interest, and employee sentiment are unavailable; confidence should therefore remain moderate.
RankAlpha Sentiment Codex - 2026-08-18
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-11-16eventFollow-through on reaffirmed FY2026 guidanceHigh impact
Management reaffirmed full-year 2026 revenue and Adjusted EBITDA guidance. The next company update should test whether positive operating cash flow, subscriber stability, and reduced marketing intensity are translating into sustained execution. [#SEC-8K-2026-08-05]
2026-11-16catalystClinical and Core+ mix shift continuesMedium impact
Q2 clinical subscription revenue grew 30.4% year over year, clinical subscribers grew 55.7%, Core+ subscribers grew 13.9%, and ARPU increased 10.2%. The setup remains constructive if premium-tier growth continues to offset pressure in the legacy Behavioral base. [#SEC-8K-2026-08-05]
2027-08-18catalystHigher-value membership transitionHigh impact
The longer-term thesis depends on Clinical and Core+ growth, improved ARPU, and operational discipline becoming durable enough to offset secular declines in the traditional Behavioral tier. [#SEC-8K-2026-08-05]
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-18 • Updated nightlySource: Internal modelMethodology